View in EDS PDF Full Text

Genomewide association for schizophrenia in the CATIE study: results of stage 1.

Saved in:
Bibliographic Details
Title: Genomewide association for schizophrenia in the CATIE study: results of stage 1.
Authors: Sullivan, P. F., Lin, D., Tzeng, J-Y, van den Oord, E., Perkins, D., Stroup, T. S., Wagner, M., Lee, S., Wright, F. A., Zou, F., Liu, W., Downing, A. M., Lieberman, J., Close, S. L.
Source: Molecular Psychiatry. Jun2008, Vol. 13 Issue 6, p570-584. 15p. 5 Charts, 1 Graph.
Subjects: Schizophrenia, Psychoses, Regression analysis, Genetic polymorphisms, Genetic research
Abstract: Little is known for certain about the genetics of schizophrenia. The advent of genomewide association has been widely anticipated as a promising means to identify reproducible DNA sequence variation associated with this important and debilitating disorder. A total of 738 cases with DSM-IV schizophrenia (all participants in the CATIE study) and 733 group-matched controls were genotyped for 492 900 single-nucleotide polymorphisms (SNPs) using the Affymetrix 500K two-chip genotyping platform plus a custom 164K fill-in chip. Following multiple quality control steps for both subjects and SNPs, logistic regression analyses were used to assess the evidence for association of all SNPs with schizophrenia. We identified a number of promising SNPs for follow-up studies, although no SNP or multimarker combination of SNPs achieved genomewide statistical significance. Although a few signals coincided with genomic regions previously implicated in schizophrenia, chance could not be excluded. These data do not provide evidence for the involvement of any genomic region with schizophrenia detectable with moderate sample size. However, a planned genomewide association study for response phenotypes and inclusion of individual phenotype and genotype data from this study in meta-analyses hold promise for eventual identification of susceptibility and protective variants.Molecular Psychiatry (2008) 13, 570–584; doi:10.1038/mp.2008.25; published online 18 March 2008 [ABSTRACT FROM AUTHOR]
Copyright of Molecular Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 32066455
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Genomewide association for schizophrenia in the CATIE study: results of stage 1.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Sullivan%2C+P%2E+F%2E%22">Sullivan, P. F.</searchLink><br /><searchLink fieldCode="AR" term="%22Lin%2C+D%2E%22">Lin, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Tzeng%2C+J-Y%22">Tzeng, J-Y</searchLink><br /><searchLink fieldCode="AR" term="%22van+den+Oord%2C+E%2E%22">van den Oord, E.</searchLink><br /><searchLink fieldCode="AR" term="%22Perkins%2C+D%2E%22">Perkins, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Stroup%2C+T%2E+S%2E%22">Stroup, T. S.</searchLink><br /><searchLink fieldCode="AR" term="%22Wagner%2C+M%2E%22">Wagner, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Lee%2C+S%2E%22">Lee, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Wright%2C+F%2E+A%2E%22">Wright, F. A.</searchLink><br /><searchLink fieldCode="AR" term="%22Zou%2C+F%2E%22">Zou, F.</searchLink><br /><searchLink fieldCode="AR" term="%22Liu%2C+W%2E%22">Liu, W.</searchLink><br /><searchLink fieldCode="AR" term="%22Downing%2C+A%2E+M%2E%22">Downing, A. M.</searchLink><br /><searchLink fieldCode="AR" term="%22Lieberman%2C+J%2E%22">Lieberman, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Close%2C+S%2E+L%2E%22">Close, S. L.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Molecular+Psychiatry%22">Molecular Psychiatry</searchLink>. Jun2008, Vol. 13 Issue 6, p570-584. 15p. 5 Charts, 1 Graph.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Schizophrenia%22">Schizophrenia</searchLink><br /><searchLink fieldCode="DE" term="%22Psychoses%22">Psychoses</searchLink><br /><searchLink fieldCode="DE" term="%22Regression+analysis%22">Regression analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Genetic+polymorphisms%22">Genetic polymorphisms</searchLink><br /><searchLink fieldCode="DE" term="%22Genetic+research%22">Genetic research</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Little is known for certain about the genetics of schizophrenia. The advent of genomewide association has been widely anticipated as a promising means to identify reproducible DNA sequence variation associated with this important and debilitating disorder. A total of 738 cases with DSM-IV schizophrenia (all participants in the CATIE study) and 733 group-matched controls were genotyped for 492 900 single-nucleotide polymorphisms (SNPs) using the Affymetrix 500K two-chip genotyping platform plus a custom 164K fill-in chip. Following multiple quality control steps for both subjects and SNPs, logistic regression analyses were used to assess the evidence for association of all SNPs with schizophrenia. We identified a number of promising SNPs for follow-up studies, although no SNP or multimarker combination of SNPs achieved genomewide statistical significance. Although a few signals coincided with genomic regions previously implicated in schizophrenia, chance could not be excluded. These data do not provide evidence for the involvement of any genomic region with schizophrenia detectable with moderate sample size. However, a planned genomewide association study for response phenotypes and inclusion of individual phenotype and genotype data from this study in meta-analyses hold promise for eventual identification of susceptibility and protective variants.Molecular Psychiatry (2008) 13, 570–584; doi:10.1038/mp.2008.25; published online 18 March 2008 [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Molecular Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=32066455
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/mp.2008.25
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 15
        StartPage: 570
    Subjects:
      – SubjectFull: Schizophrenia
        Type: general
      – SubjectFull: Psychoses
        Type: general
      – SubjectFull: Regression analysis
        Type: general
      – SubjectFull: Genetic polymorphisms
        Type: general
      – SubjectFull: Genetic research
        Type: general
    Titles:
      – TitleFull: Genomewide association for schizophrenia in the CATIE study: results of stage 1.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sullivan, P. F.
      – PersonEntity:
          Name:
            NameFull: Lin, D.
      – PersonEntity:
          Name:
            NameFull: Tzeng, J-Y
      – PersonEntity:
          Name:
            NameFull: van den Oord, E.
      – PersonEntity:
          Name:
            NameFull: Perkins, D.
      – PersonEntity:
          Name:
            NameFull: Stroup, T. S.
      – PersonEntity:
          Name:
            NameFull: Wagner, M.
      – PersonEntity:
          Name:
            NameFull: Lee, S.
      – PersonEntity:
          Name:
            NameFull: Wright, F. A.
      – PersonEntity:
          Name:
            NameFull: Zou, F.
      – PersonEntity:
          Name:
            NameFull: Liu, W.
      – PersonEntity:
          Name:
            NameFull: Downing, A. M.
      – PersonEntity:
          Name:
            NameFull: Lieberman, J.
      – PersonEntity:
          Name:
            NameFull: Close, S. L.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: Jun2008
              Type: published
              Y: 2008
          Identifiers:
            – Type: issn-print
              Value: 13594184
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Molecular Psychiatry
              Type: main
ResultId 1